Toll Free: 1-888-928-9744

LegoChem Biosciences, Inc - Product Pipeline Review - 2014

Published: Jun, 2014 | Pages: 29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

LegoChem Biosciences, Inc - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'LegoChem Biosciences, Inc - Product Pipeline Review - 2014', provides an overview of the LegoChem Biosciences, Inc's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of LegoChem Biosciences, Inc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of LegoChem Biosciences, Inc including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of LegoChem Biosciences, Inc's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the LegoChem Biosciences, Inc's pipeline products

Reasons to buy

- Evaluate LegoChem Biosciences, Inc's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of LegoChem Biosciences, Inc in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the LegoChem Biosciences, Inc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of LegoChem Biosciences, Inc and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of LegoChem Biosciences, Inc
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of LegoChem Biosciences, Inc and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
LegoChem Biosciences, Inc Snapshot 5
LegoChem Biosciences, Inc Overview 5
Key Information 5
Key Facts 5
LegoChem Biosciences, Inc - Research and Development Overview 6
Key Therapeutic Areas 6
LegoChem Biosciences, Inc - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
LegoChem Biosciences, Inc - Pipeline Products Glance 14
LegoChem Biosciences, Inc - Clinical Stage Pipeline Products 14
Phase I Products/Combination Treatment Modalities 14
LegoChem Biosciences, Inc - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
LegoChem Biosciences, Inc - Drug Profiles 17
LCB-010371 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
LCB-030110 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecule to Inhibit Blood Factor VIa/XIa for Blood Coagulation 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecule to Inhibit Hypoxia inducible factor-1 for Ophthalmology 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecules to Inhibit Heat Shock Protein 90 for Oncology 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
LegoChem Biosciences, Inc - Pipeline Analysis 22
LegoChem Biosciences, Inc - Pipeline Products by Target 22
LegoChem Biosciences, Inc - Pipeline Products by Route of Administration 23
LegoChem Biosciences, Inc - Pipeline Products by Molecule Type 24
LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action 25
LegoChem Biosciences, Inc - Dormant Projects 26
LegoChem Biosciences, Inc - Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29
List of Tables
LegoChem Biosciences, Inc, Key Information 5
LegoChem Biosciences, Inc, Key Facts 5
LegoChem Biosciences, Inc - Pipeline by Indication, 2014 7
LegoChem Biosciences, Inc - Pipeline by Stage of Development, 2014 8
LegoChem Biosciences, Inc - Monotherapy Products in Pipeline, 2014 9
LegoChem Biosciences, Inc - Partnered Products in Pipeline, 2014 10
LegoChem Biosciences, Inc - Partnered Products/ Combination Treatment Modalities, 2014 11
LegoChem Biosciences, Inc - Out-Licensed Products in Pipeline, 2014 12
LegoChem Biosciences, Inc - Out-Licensed Products/ Combination Treatment Modalities, 2014 13
LegoChem Biosciences, Inc - Phase I, 2014 14
LegoChem Biosciences, Inc - Preclinical, 2014 15
LegoChem Biosciences, Inc - Discovery, 2014 16
LegoChem Biosciences, Inc - Pipeline by Target, 2014 22
LegoChem Biosciences, Inc - Pipeline by Route of Administration, 2014 23
LegoChem Biosciences, Inc - Pipeline by Molecule Type, 2014 24
LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action, 2014 25
LegoChem Biosciences, Inc - Dormant Developmental Projects,2014 26 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify